Advanced Micro Devices AMD is slated to release first-quarter 2020 results on Apr 28.Ongoing momentum in Ryzen, Radeon and EPYC products are expected to have the to-be-reported quarter’s performance. Further, robust demand for graphic processor units (GPUs), which are now wide
The Clorox Company CLX is slated to report third-quarter fiscal 2020 results on May 1, before market open. In the last reported quarter, the Oakland, CA-based manufacturer and marketer of consumer products delivered a positive earnings surprise of 11.5%. Moreover, it delivered a
Microsoft MSFT is scheduled to report third-quarter fiscal 2020 results on Apr 29.The tech giant has been striving to enhance capabilities of its cloud computing service — Azure, which is likely to have bolstered adoption. This, in turn, is likely to have contributed to the fi
A dramatic change in the economy has been noticed over the past three months, thanks to the coronavirus pandemic that also put an abrupt end to the longest bullish run in the America’s stock market history. In fact, the COVID-19 outbreak has claimed innumerable lives and broug
Monday, April 27, 2020We start off slowly in our new trading week, especially considering we will be getting Q1 earnings results from no fewer than 150 companies listed on the S&P 500, as well as 1/3 of the Dow Jones. We are currently in the heart of earnings season, though
The Kraft Heinz Company KHC is scheduled to report first-quarter 2020 financial results on Apr 30, before the market opens. In the trailing three quarters, the company’s bottom line outperformed the Zacks Consensus Estimate by 13.4%, on average. In the last reported quarter, t
Given the current volatile markets amid coronavirus-related mayhem, it is very difficult for retail investors to choose stocks on their own. With the first-quarter earnings season in full steam, market sentiments are easily influenced by corporate results and guidance.Therefore,
Amazon AMZN is scheduled to report first-quarter 2020 results on Apr 30.We note that the Zacks Consensus Estimate for first-quarter 2020 earnings currently stands at $6.35 per share, down 1.1% over the past 30 days. The figure suggests a decline of 10.4% from the year-ago quarte
NIC (EGOV) came out with quarterly earnings of $0.18 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items.
This week will be a full plate for investors given the volume of quarterly earnings to be reported, several key central bank meetings, and the latest pandemic developments, including a growing number of plans being released to open economies in Europe and the US
As of April 24, nine S&P 500 companies had suspended their dividends this month and about half a dozen others announced decreases because of the fallout from the coronavirus pandemic.
Check Point Software (CHKP) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.38 per share. This compares to earnings of $1.32 per share a year ago. These figures are adjusted for non-recurring items.
Armstrong World Industries (AWI) came out with quarterly earnings of $1.10 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.10 per share a year ago. These figures are adjusted for non-recurring items.
As Americans delay elective surgeries and avoid doctors and hospitals during the coronavirus pandemic, healthcare spending declines have more than offset the added costs of COVID-19 care, insurance executives and experts say, boosting U.S. health insurer profits.
The Federal Reserve's gradual withdrawal from the U.S. Treasury market as the coronavirus pandemic eases and liquidity improves could dry up appetite for longer-dated government debt and push up long-term interest rates months from now.
Quarantines and lockdowns at large U.S. power plants are threatening to squeeze a multibillion-dollar slice of revenue that General Electric Co is counting on to help lift profits.
Investors are pinning their hopes for the reopening of the U.S. economy on the potential for wider availability of testing for COVID-19 cases and on drug trials for treatments of the deadly disease